Colorado Kidney Care

Denver, Colorado 80230-7200

4 studies enrolling now · 12 studies all time

What they study most

Calcific Uremic Arteriolopathy, Calciphylaxis, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Kidney Diseases, Diabetic Nephropathies, End Stage Kidney Disease, End Stage Renal Disease on Dialysis, Focal Segmental Glomerulosclerosis, Glomerulosclerosis, Focal Segmental, Hyperphosphatemia, Immunoglobulin A Nephropathy, Kidney Disease, Chronic

Studies at this site

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease — Recruiting now
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) — Recruiting now
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia — Recruiting now
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) — Completed
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis — Completed
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed
Phase 3 Study of SNF472 for Calciphylaxis — Completed
A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN) — Stopped early
Rituximab and Belimumab for Lupus Nephritis — Completed
The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population — Status unconfirmed